These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19269291)

  • 1. Effects of acidic-astressin and ovine-CRF microinfusions into the ventral hippocampus on defensive behaviors in rats.
    Pentkowski NS; Litvin Y; Blanchard DC; Vasconcellos A; King LB; Blanchard RJ
    Horm Behav; 2009 Jun; 56(1):35-43. PubMed ID: 19269291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of lesions to the dorsal and ventral hippocampus on defensive behaviors in rats.
    Pentkowski NS; Blanchard DC; Lever C; Litvin Y; Blanchard RJ
    Eur J Neurosci; 2006 Apr; 23(8):2185-96. PubMed ID: 16630065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of corticotropin releasing factor-containing neurons in the rat central amygdala and bed nucleus of the stria terminalis following exposure to two different anxiogenic stressors.
    Butler RK; Oliver EM; Sharko AC; Parilla-Carrero J; Kaigler KF; Fadel JR; Wilson MA
    Behav Brain Res; 2016 May; 304():92-101. PubMed ID: 26821289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortagine infused into the medial prefrontal cortex attenuates predator-induced defensive behaviors and Fos protein production in selective nuclei of the amygdala in male CD1 mice.
    Pentkowski NS; Tovote P; Zavala AR; Litvin Y; Blanchard DC; Spiess J; Blanchard RJ
    Horm Behav; 2013 Aug; 64(3):519-26. PubMed ID: 23845323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).
    Yang M; Farrokhi C; Vasconcellos A; Blanchard RJ; Blanchard DC
    Behav Brain Res; 2006 Jul; 171(1):1-8. PubMed ID: 16621042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.
    Radulovic J; Rühmann A; Liepold T; Spiess J
    J Neurosci; 1999 Jun; 19(12):5016-25. PubMed ID: 10366634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonergic projection from the median raphe nucleus to the ventral hippocampus is involved in the retrieval of fear memory through the corticotropin-releasing factor type 2 receptor.
    Ohmura Y; Izumi T; Yamaguchi T; Tsutsui-Kimura I; Yoshida T; Yoshioka M
    Neuropsychopharmacology; 2010 May; 35(6):1271-8. PubMed ID: 20072117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.
    Takahashi LK; Ho SP; Livanov V; Graciani N; Arneric SP
    Brain Res; 2001 Jun; 902(2):135-42. PubMed ID: 11384606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the effects of 2-phenylethylamine and coyote urine on unconditioned and conditioned defensive behaviors in adolescent male and female Long-Evans hooded rats.
    Pentkowski NS; Maestas-Olguin C; Martinez G
    Physiol Behav; 2022 May; 248():113726. PubMed ID: 35122825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column.
    Borelli KG; Brandão ML
    Horm Behav; 2008 Jan; 53(1):40-50. PubMed ID: 17920596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intra-PAG infusion of ovine CRF on defensive behaviors in Swiss-Webster mice.
    Carvalho-Netto EF; Litvin Y; Nunes-de-Souza RL; Blanchard DC; Blanchard RJ
    Behav Brain Res; 2007 Jan; 176(2):222-9. PubMed ID: 17095103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-specific threats induce CRF expression in the paraventricular nucleus of the hypothalamus and hippocampus of young rats.
    Wiedenmayer CP; Magariños AM; McEwen BS; Barr GA
    Horm Behav; 2005 Feb; 47(2):139-50. PubMed ID: 15664017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
    Tezval H; Jahn O; Todorovic C; Sasse A; Eckart K; Spiess J
    Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9468-73. PubMed ID: 15192151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of central CRF receptor 1 by cortagine results in enhanced passive coping with a naturalistic threat in mice.
    Tovote P; Farrokhi CB; Gonzales RM; Schnitzbauer U; Blanchard DC; Blanchard RJ; Spiess J
    Psychoneuroendocrinology; 2010 Jul; 35(6):887-95. PubMed ID: 20036073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estrus cycle stage on defensive behavior in female Long-Evans hooded rats.
    Pentkowski NS; Litvin Y; Blanchard DC; Blanchard RJ
    Physiol Behav; 2018 Oct; 194():41-47. PubMed ID: 29689249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blockage of ventromedial hypothalamus CRF type 2 receptors impairs escape responses in the elevated T-maze.
    Silva MSCF; Souza TMO; Pereira BA; Ribeiro DA; Céspedes IC; Bittencourt JC; Viana MB
    Behav Brain Res; 2017 Jun; 329():41-50. PubMed ID: 28435125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coyote urine, but not 2-phenylethylamine, induces a complete profile of unconditioned anti-predator defensive behaviors.
    Maestas-Olguin CR; Parish MM; Pentkowski NS
    Physiol Behav; 2021 Feb; 229():113210. PubMed ID: 33068564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential dose effects of central CRF and effects of CRF astressin on pig behavior.
    Salak-Johnson JL; Anderson DL; McGlone JJ
    Physiol Behav; 2004 Oct; 83(1):143-50. PubMed ID: 15501501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
    Pelleymounter MA; Joppa M; Ling N; Foster AC
    J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors.
    Perrin MH; Sutton SW; Cervini LA; Rivier JE; Vale WW
    J Pharmacol Exp Ther; 1999 Feb; 288(2):729-34. PubMed ID: 9918582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.